Earnings Preview: Nuwellis to Report Financial Results on March 11
$Nuwellis(NUWE.US)$ is scheduled to release its financial results on March 11 ET. Earnings PreviewAnalysts estimate $Nuwellis(NUWE.US)$ to post revenue of USD2.46M for 2024Q4, down 3.51% YoY; EPS is
Healthcare Up as Traders Rotate to Less Inflation-Sensitive Sectors -- Health Care Roundup
Nuwellis, Inc. Earnings Call: Mixed Results With Promising Prospects
Nuwellis, Inc. Reports 2024 Financial Results and Strategic Progress
10-K: FY2024 Annual Report
Nuwellis, Inc. (NUWE) Q4 2024 Earnings Call Transcript Summary
8-K: Nuwellis, Inc. Announces Fourth Quarter and Full Year 2024 Financial Results
Nuwellis Q4 2024 GAAP EPS $(0.44) Misses $(0.43) Estimate, Sales $2.32M Miss $2.46M Estimate
Nuwellis GAAP EPS of -$0.44 Misses by $0.01, Revenue of $2.32M Misses by $0.14M
Nuwellis 4Q Loss/Shr 44c >NUWE
Nuwellis 4Q Sales $2.32M >NUWE
Earnings Scheduled For March 11, 2025
Nuwellis Appoints John Erb as Interim CEO
Express News | Nuwellis Inc - John Erb Assumes Role of Interim President and CEO of Nuwellis
Express News | Nuwellis Announces Retirement of Nestor Jaramillo, Jr. as President and CEO
Press Release: Nuwellis Announces Retirement of Nestor Jaramillo, Jr. as President and CEO
JACC: Heart Failure Paper Reports Promising Findings of Aquadex Therapy in Updated AVOID-HF Study Analysis
Nuwellis, Inc. To Report Fourth Quarter and Full Year 2024 Financial Results on March 11, 2025
Home Healthcare Inflation Is Stubbornly High -- WSJ
On January 29, Nuwellis Posted On X "Big News! As of January 1, 2025, the Reimbursement for Aquadex Just Quadrupled Under APC 5242, Making It a Game-changer for Outpatient Care! Are You Ready to Lead the Way in Patient Treatment and Maximize Your...